Skip to content

Clinical trials

Mesothelioma, Malignant trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20142
20151
20161
20172
20191
20202
20213
20222
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Active, not recruiting4
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aminex Therapeutics, Inc.1
Asbestos Diseases Research Foundation1
AstraZeneca1
Checkpoint Therapeutics, Inc.1
Ferring Ventures Limited1
Ikena Oncology1
MedImmune LLC1
Medicenna Therapeutics, Inc.1
Morphotek1
Multitude Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant19
Neoplasms6
Mesothelioma5
Ovarian Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms4
Endometrial Neoplasms4
Melanoma4
Stomach Neoplasms4
Esophageal Neoplasms3

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.